Innate Immunity

$530,764U19FY2015AINIH

Emory University, Atlanta GA

Investigators

Linked publications, trials & patents

Paper 39605357 Paper 39510068 Paper 39476472 Paper 39465249 Paper 39003273 Paper 38895386 Paper 38861769 Paper 38828640 Paper 38711126 Paper 38599937 Paper 38579013 Paper 38456511 Paper 38329813 Paper 38129234 Paper 37932847 Paper 37822504 Paper 37776858 Paper 37672564 Paper 37662959 Paper 37624867 Paper 37542986 Paper 37537502 Paper 37500727 Paper 37494738 Paper 37468586 Paper 37443176 Paper 37155869 Paper 37119870 Paper 37118554 Paper 37085898 Paper 37066221 Paper 36884349 Paper 36860353 Paper 36807070 Paper 36807067 Paper 36717665 Paper 36656970 Paper 36597536 Paper 36577930 Paper 36563664 Paper 36546661 Paper 36516854 Paper 36510022 Paper 36482977 Paper 36456737 Paper 36420636 Paper 36419548 Paper 36357240 Paper 36316475 Paper 36256473 Paper 36253572 Paper 36171288 Paper 35988541 Paper 35976993 Paper 35976000 Paper 35952496 Paper 35907675 Paper 35862190 Paper 35739396 Paper 35730568 Paper 35726067 Paper 35590141 Paper 35588691 Paper 35525727 Paper 35501385 Paper 35480625 Paper 35463156 Paper 35361968 Paper 35325819 Paper 35288714 Paper 35233550 Paper 35232465 Paper 35210622 Paper 35183062 Paper 35141865 Paper 35087093 Paper 35085847 Paper 35037030 Paper 34942633 Paper 34931200 Paper 34924297 Paper 34811544 Paper 34781736 Paper 34758299 Paper 34688983 Paper 34623901 Paper 34478460 Paper 34358128 Paper 34341533 Paper 34312615 Paper 34252919 Trial NCT01290055 Trial NCT01244802 Trial NCT00694655 Patent 9511086 Patent 9469685 Patent 9458226 Patent 9321829 Patent 8685938 Patent 8563305

Abstract

The goal of this proposal is to determine the molecular mechanisms by which flaviviruses, notably the yellow fever vaccine strain YFV-17D and the pathogenic Asibi strain, as well as dengue virus (DENV), stimulate innate immunity to program adaptive immune responses. This broad goal will be pursued in 3 aims: Specific Aim 1: To determine the mechanisms by which ISR programs DCs to stimulate adaptive Immunity. Our recent use of systems biological approaches to understand immune responses to vaccination in humans has revealed an early transcriptional signature, consisting of mammalian general control nonderepressible-2 [GCN2], that is a strong correlate of the later CD8+ T cell response. GCN2 is a sensor of amino acid starvation, and mediates the integrated stress response (ISR) and translational control of mRNA. We will thus study the impact of the ISR and translational control in the innate control of adaptive immunity. Specific Aim 2: To evaluate the Innate and adaptive immune responses stimulated by YFV-17D, versus Aslbl. YFV-17D was derived from the Asibi strain, but very little is understood about the mechanisms of innate sensing and regulation of adaptive immunity by Asibi. Here we will use molecular clones of the two viruses to determine the signaling networks by which these two viruses program DCs and monocytes, and the impact of this on T and B cell immunity. Specific Aim 3: To determine the development and functions of human monocyte subsets In response to DENV. Our recent work demonstrates that during acute dengue infection, there is a substantial expansion in the CD14+CD16+ monocyte population. This subset seems to be efficient at inducing plasmablast differentiation from resting B cells. Here we will explore the immune stimulatory capacities and developmental programs of these cells. Sub-Aim 3a: To determine the Immune stimulatory capacity of monocytes stimulated by DENV; Sub-Aim 3b: Probing the gene regulatory networks driving differentiation of CD14+CD16+ monocytes The successful completion of these aims will offer novel insights into the mechanisms by which flaviviruses stimulate innate immunity, and guide the design of therapeutic and vaccination strategies.

View original record on NIH RePORTER →